The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cancer‐Cell‐Specific Induction of Apoptosis Using Mesoporous Silica Nanoparticles as Drug‐Delivery Vectors
Abstract
Targeted delivery of the chemotherapeutic agent methotrexate (MTX) to cancer cells using poly(ethyleneimine)‐functionalized mesoporous silica particles as drug‐delivery vectors is reported. Due to its high affinity for folate receptors, the expression of which is elevated in cancer cells, MTX serves as both a targeting ligand and a cytotoxic agent. Enhanced cancer‐cell apoptosis (programmed cell death) relative to free MTX is thus observed at particle concentrations where nonspecific MTX‐induced apoptosis is not observed in the nontargeted healthy cell line, while corresponding amounts of free drug affect both cell lines equally. The particles remain compartmentalized in endo‐/lysosomes during the time of observation (up to 72 h), while the drug is released from the particle only upon cell entry, thereby inducing selective apoptosis in the target cells. As MTX is mainly attached to the particle surface, an additional advantage is that the presented carrier design allows for adsorption (loading) of additional drugs into the pore network for therapies based on a combination of drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Cited by
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Tang, F., Li, L., & Chen, D. (2012) · Advanced Materials · doi:10.1002/adma.201104763 · Cited by 2,836
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Applications of advanced hybrid organic–inorganic nanomaterials: from laboratory to market
Sanchez, C., Belleville, P., Popall, M., & Nicole, L. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00136h · Cited by 1,462
Pan, L., He, Q., Liu, J., Chen, Y., Ma, M., Zhang, L., & Shi, J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211035w · Cited by 984
Chen, Y., Chen, H., & Shi, J. (2013) · Advanced Materials · doi:10.1002/adma.201205292 · Cited by 724
Rosenholm, J. M., Sahlgren, C., & Lindén, M. (2010) · Nanoscale · doi:10.1039/c0nr00156b · Cited by 572
Self-citationMesoporous Silica Nanoparticles for Drug Delivery: Current Insights
Vallet-Regí, M., Colilla, M., Izquierdo-Barba, I., & Manzano, M. (2017) · Molecules · doi:10.3390/molecules23010047 · Cited by 538
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 507
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Nanocarriers for drug delivery applications
Chamundeeswari, M., Jeslin, J., & Verma, M. L. (2019) · Environmental Chemistry Letters · doi:10.1007/s10311-018-00841-1 · Cited by 444
Luo, Z., Cai, K., Hu, Y., Zhao, L., Liu, P., Duan, L., & Yang, W. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005061 · Cited by 440
Mesoporous silica nanoparticles as nanocarriers
Wu, S.-H., Hung, Y., & Mou, C.-Y. (2011) · Chemical Communications · doi:10.1039/c1cc11760b · Cited by 372
Li, Z., Zhang, Y., & Feng, N. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1575806 · Cited by 321
Multifunctional hybrids by combining ordered mesoporous materials and macromolecular building blocks
Soler-Illia, G. J. A. A., & Azzaroni, O. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00208a · Cited by 305
Arcos, D., & Vallet-Regí, M. (2013) · Acta Materialia · doi:10.1016/j.actamat.2012.10.039 · Cited by 282
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
Baeza, A., Colilla, M., & Vallet-Regí, M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.953051 · Cited by 270
Hartono, S. B., Gu, W., Kleitz, F., Liu, J., He, L., Middelberg, A. P. J., Yu, C., Lu, G. Q. (., & Qiao, S. Z. (2012) · ACS Nano · doi:10.1021/nn2039643 · Cited by 264
Shadmani, N., Makvandi, P., Parsa, M., Azadi, A., Nedaei, K., Mozafari, N., Poursina, N., Mattoli, V., Tay, F. R., Maleki, A., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00755 · Cited by 48
Tumor cell targeted delivery by specific peptide-modified mesoporous silica nanoparticles
Wang, Y., Shi, W., Song, W., Wang, L., Liu, X., Chen, J., & Huang, R. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm32398b · Cited by 46
Metadata
- Authors
- Rosenholm, J. M., Peuhu, E., Bate‐Eya, L. T., Eriksson, J. E., Sahlgren, C., & Lindén, M.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2010-05-31
- Volume
- 6
- Issue
- 11
- Pages
- 1234-1241
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W2130648675
- Cited by
- 186
- References
- 1
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.